Skip to content
The BFD.

This post is for paying subscribers only

Subscribe

Already have an account? Sign In

Latest

WHO’s High-Price Pandemic Plan

WHO’s High-Price Pandemic Plan

Unfortunately, incentives without accountability are a poor basis for health governance. It matters because funds to finance the pharmaceutical corporations, research institutions, and bureaucrats who stand to benefit from the pandemic agenda will have to be diverted from programs that work.

Members Public